31 July 2021 | Saturday | News
Image Source : 3BLMedia
Under the collaboration, (i) EC Healthcare shall be the designated offline fulfillment partner of Prenetics online business; (ii) EC Healthcare shall be granted the exclusive license to market and sell certain Prenetics DNA testing products under the CircleDNA and Circle Medical brand in the Greater Bay Area; (iii) EC Healthcare shall be the marketing and operational partners to promote Prenetics diagnostic and genetic testing products; and (iv) EC Healthcare and Prenetics shall jointly develop necessary IT solutions to enhance the integration of health data resources and genomics data resources.
Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare, said, "The Group is delighted to establish a strategic partnership with Prenetics. Through the collaboration, we hope to divert public domain traffic into EC Healthcare's enclosed ecosystem by using Prenetics testing services and form a 'Healthomics collaboration' which will combine traditional blood-based health data and genomics risk profiling data for patients to have a holistic view on their overall health. Furthermore, the Group believes that the collaboration can promote cross-selling synergies between the Group and Prenetics, thereby creating new source of clientele and income for the Group's existing medical, aesthetic medical and wellness businesses, and enhance the loyalty of the Group's existing customers by complementing the scope of preventive and precision medical services provided."
Mr. Danny Yeung, Chief Executive Officer and Co-Founder of Prenetics, said, "We are thrilled to partner with EC Healthcare, the largest non-hospital medical group in Hong Kong. By integrating our tests to EC Healthcare's health checks and medical services, it will provide a first of its kind offering to patients which combines DNA and health data into one consolidated view. Our mission has always been about prevention, not treatment. This partnership with EC Healthcare further allows us to create new opportunities to revolutionize personalized healthcare."